5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.

[1]  P. Minard,et al.  Inactivation of 3 alpha-hydroxysteroid dehydrogenase by superoxide radicals. Modification of histidine and cysteine residues causes the conformational change. , 1986, The Biochemical journal.

[2]  J. Vennerstrom,et al.  Inhibition of cyclooxygenase mediated by electrochemical oxidation of gentisic acid. , 1985, The Journal of biological chemistry.

[3]  J. Singh,et al.  Pyruvate and related alpha-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. , 1985, Toxicology letters.

[4]  J. V. van Rossum,et al.  Disposition of disodium azodisalicylate in healthy subjects. A possible new drug for inflammatory bowel disease. , 1985, Gastroenterology.

[5]  J. Rask-Madsen,et al.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls. , 1984, Gut.

[6]  S. Hansen,et al.  The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs. , 1984, Scandinavian journal of gastroenterology.

[7]  M. Cunningham,et al.  Superoxide anion generated by potassium superoxide is cytotoxic and mutagenic to chinese hamster ovary cells. , 1983, Mutation research.

[8]  R. Wilson,et al.  Hydroxyl-free radicals and anti-inflammatory drugs: biological inactivation studies and reaction rate constants. , 1983, Biochemical Pharmacology.

[9]  G. Labó,et al.  TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS , 1981, The Lancet.

[10]  K Heinkel,et al.  Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. , 1980, The New England journal of medicine.

[11]  J. V. van Tongeren,et al.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. , 1980, Gut.

[12]  J. A. Badwey,et al.  Active oxygen species and the functions of phagocytic leukocytes. , 1980, Annual review of biochemistry.

[13]  A. Tauber,et al.  O2‐ AND HOST DEFENSE: THE PRODUCTION AND FATE OF O2‐ IN NEUTROPHILS *, § , 1978, Photochemistry and photobiology.

[14]  U. Zor,et al.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. , 1978, Gastroenterology.

[15]  D. Armstrong,et al.  REACTIONS OF O‐2, H2O2 AND OTHER OXIDANTS WITH SULFHYDRYL ENZYMES‡ , 1978, Photochemistry and photobiology.

[16]  S. Truelove,et al.  AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE , 1977, The Lancet.

[17]  A. Bøyum.  Isolation of lymphocytes, granulocytes and macrophages. , 1976, Scandinavian journal of immunology.

[18]  D. Cornwell,et al.  Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. , 1976, Prostaglandins.

[19]  E. W. Kellogg,et al.  Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. , 1975, The Journal of biological chemistry.

[20]  J. V. van Hemmen,et al.  Inactivation of biologically active DNA by gamma-ray-induced superoxide radicals and their dismutation products singlet molecular oxygen and hydrogen peroxide. , 1975, Biochimica et biophysica acta.

[21]  G. J. Blackwell,et al.  Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes. , 1975, Biochimica et biophysica acta.

[22]  M. Peppercorn,et al.  Drug therapy: Sulfasalazine. , 1975, The New England journal of medicine.

[23]  M. Buckingham,et al.  Effects of superoxide radicals on myoblast growth and differentiation. , 1974, Biochemical and biophysical research communications.

[24]  R. W. Fessenden,et al.  Hydroxyl radical reactions with phenols and anilines as studied by electron spin resonance , 1974 .

[25]  M. Peppercorn,et al.  Distribution studies of salicylazosulfapyridine and its metabolites. , 1973, Gastroenterology.

[26]  M. Peppercorn,et al.  The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. , 1972, The Journal of pharmacology and experimental therapeutics.

[27]  Thomas We,et al.  Enteric fever apparently spread by pasteurized milk. , 1948 .

[28]  H. Fenton,et al.  I.—The oxidation of polyhydric alcohols in presence of iron , 1899 .